Adverse Events Following Trivalent Inactivated Influenza Vaccination in Children: Analysis of the Vaccine Adverse Event Reporting System
- PMID: 21042229
- DOI: 10.1097/INF.0b013e3181ff9795
Adverse Events Following Trivalent Inactivated Influenza Vaccination in Children: Analysis of the Vaccine Adverse Event Reporting System
Abstract
Background: The Advisory Committee on Immunization Practices' recommendations for influenza vaccination of children have expanded from the long-standing recommendation to vaccinate high-risk children aged ≥6 months, to vaccinating all 6- to 23-month-olds (2004), 2- to 4-year-olds (2006), and 5- to 18-year-olds (2008).
Objective: To identify new or unexpected adverse events (AEs) after trivalent inactivated vaccine (TIV) in children.
Methods: We analyzed reports after TIV to the Vaccine Adverse Event Reporting System from 1990-2006 in children aged 2 to 17 years, and from the 2008-2009 influenza season in children aged 5 to 17 years. Empiric Bayesian data mining techniques were used to identify new or unexpected AEs during 1990-2006.
Results: During 1990-2006, the Vaccine Adverse Event Reporting System received 2054 reports of children aged 2 to 17 years with a peak in the 2003-2004 influenza season. In 2008-2009, 506 reports describing 5 to 17 year olds were received. The serious reports of tests performed after TIV were approximately 10% of all reports from 2001-2006, and 6% of the reports in the 2008-2009 season. Data mining showed an increased proportion of medication errors and Guillain Barré Syndrome (GBS). The findings of GBS could not be interpreted as causally related to vaccination. Among 201 reports of medication error, 94% had no AE reported other than the medication error itself.
Conclusion: In this analysis, we found no unexpected AEs. Our review of medication error and GBS reports suggests that ongoing monitoring in these areas is appropriate.
Similar articles
-
Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.Pediatrics. 2005 Feb;115(2):453-60. doi: 10.1542/peds.2004-1519. Pediatrics. 2005. PMID: 15687455
-
Post-Licensure Surveillance of Trivalent Live-Attenuated Influenza Vaccine in Children Aged 2-18 Years, Vaccine Adverse Event Reporting System, United States, July 2005-June 2012.J Pediatric Infect Dis Soc. 2015 Sep;4(3):205-13. doi: 10.1093/jpids/piu034. Epub 2014 May 7. J Pediatric Infect Dis Soc. 2015. PMID: 26407428
-
Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015.Vaccine. 2016 May 11;34(22):2507-12. doi: 10.1016/j.vaccine.2016.03.048. Epub 2016 Mar 23. Vaccine. 2016. PMID: 27015735 Free PMC article. Review.
-
Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age.Vaccine. 2009 Jul 9;27(32):4278-83. doi: 10.1016/j.vaccine.2009.05.023. Epub 2009 May 28. Vaccine. 2009. PMID: 19450636
-
Safety assessment of seasonal trivalent influenza vaccine produced by Instituto Butantan from 2013 to 2017.Rev Inst Med Trop Sao Paulo. 2018 Dec 20;61:e4. doi: 10.1590/S1678-9946201961004. Rev Inst Med Trop Sao Paulo. 2018. PMID: 30570077 Free PMC article. Review.
Cited by 5 articles
-
Statement on Seasonal Influenza Vaccine for 2012-2013: Appendix I: New Evidence Review for Children 24 to 59 Months of Age: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).Can Commun Dis Rep. 2012 Aug 1;38(ACS-2):1-55. doi: 10.14745/ccdr.v38i00a02a. eCollection 2012 Aug 1. Can Commun Dis Rep. 2012. PMID: 31702744 Free PMC article. No abstract available.
-
Vaccines for preventing influenza in healthy children.Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD004879. doi: 10.1002/14651858.CD004879.pub5. Cochrane Database Syst Rev. 2018. PMID: 29388195 Free PMC article. Review.
-
Influenza vaccines: Evaluation of the safety profile.Hum Vaccin Immunother. 2018 Mar 4;14(3):657-670. doi: 10.1080/21645515.2017.1423153. Epub 2018 Jan 30. Hum Vaccin Immunother. 2018. PMID: 29297746 Free PMC article. Review.
-
Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine.Drug Saf. 2013 Jul;36(7):547-56. doi: 10.1007/s40264-013-0051-9. Drug Saf. 2013. PMID: 23657824
-
Vaccines for preventing influenza in healthy children.Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD004879. doi: 10.1002/14651858.CD004879.pub4. Cochrane Database Syst Rev. 2012. PMID: 22895945 Free PMC article. Updated. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical